HPBCD is a unique component in Janssen’s COVID-19 vaccine candidate
Amongst Janssen’s novel single-dose Covid-19 vaccine candidate of adenovirus platform excipients one might notice a peculiar compound: Hydroxypropyl Betadex (HPBCD).
Tag: Covid-19
NIH funds study to evaluate remdesivir for COVID-19 in pregnancy
A new study funded by the National Institutes of Health will evaluate the effects of remdesivir in pregnant women who
Reviews on remdesivir in Covid-19 treatment
Remdesivir (GS-5734; Gilead Sciences Inc., US) is an investigational nucleoside analog that acts as a competitive inhibitor of viral RNAdependent
RotaChrom Technologies Partners With Cyclolab to Increase Production of COVID-19 Treatment
RotaChrom Technologies, the developer of the world’s first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, announced today the launch of
Renal and liver injury following the treatment of covid-19 by remdesivir
Remdesivir initially was intravenously administrated to treat the Ebola disease however right now it has been administered to treat COVID-19
Thapsigargin repurposing for COVID-19
Whilst COVID-19 vaccines are being rolled out for mass vaccination, the modest number of antivirals in use or development for
A polypeptide, Plitidepsin has potent preclinical efficacy against SARS-CoV-2
The science reported that the drug plitidepsin (aplidin), which has limited clinical approval, possesses antiviral activity (IC90 = 0.88 nM) 27.5-fold
Novel drug for oral treatment against Covid-19
Nature Microbiology reported on an orally efficacious ribonucleoside analogue inhibitor of influenza viruses, MK-4482/EIDD-2801, that was repurposed for use against
Global Alpha-Cyclodextrin Market Outlook And Regional Analysis with Impact Analysis of COVID-19 (2021-2030)
APNEWS reported: This exhaustive Alpha-Cyclodextrin market report provides a full holistic analysis [2012-2019], market size and time frame [2021-2030], emerging
Utility of aspirin in hospitalized COVID-19 patients
A recent paper published in Anesthesia & Analgesia Journal evaluated the possible benefits of using aspirin in hospitalized COVID-19 patients